Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT02577965

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
A.O. Ospedale Papa Giovanni XXIII (from the registry)
Registry
  • NCT NCT02577965
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02577965. Randomized; double masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial
Acronym
OCTAVIA
Condition
Acute Myocardial Infarction
Intervention (Procedure)
Percutaneous Coronary Intervention
Intervention (Device)
XIENCE PRIME Everolimus Eluting Coronary Stent System
Lead sponsor
A.O. Ospedale Papa Giovanni XXIII (class: other)
Collaborator
Light Lab Imaging, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02577965
Content hash
678c6b89a619a98337d07f8819cbd1e9260ea6a7c8a4025ab307f753df1a0fd1